Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 31 January 2027
- Last conf. stmt
- 17 January 2026
SV Health Investors UK Limited
- Incorporated
- 20 September 2004 (22 years)
- Previously known as
- SV Life Sciences UK Limited (until 30 March 2017)
- Industry
- Activities of financial services holding companies (64205)
- Directors
- Nikola Trbovic
- Owned by
- Catherine Elizabeth Bingham
- Accounts type
- Group
- Region
- Greater London
- Address
- 71 KingswayLondonWC2B 6ST
Officers 3 active
Officer details are public data from the Companies House register.
Trbovic, Nikola
Director · Appointed 1 July 2024
German
Born March 1982 (44)
Director · Appointed 9 May 2018
British
Born May 1982 (44)
Director · Appointed 20 September 2004
British
Born October 1965 (61)
Officer history (5 former)
1 July 2024
Appointed Trbovic, Nikola as Director
20 July 2023
Resigned Ashrafian, Houman, Professor as Director
22 September 2022
Appointed Ashrafian, Houman, Professor as Director
9 May 2018
9 May 2018
9 May 2018
5 October 2005
5 October 2004
20 September 2004
20 September 2004
20 September 2004
20 September 2004
20 September 2004
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Individual · Notified 6 April 2016
Owns 50–75% of shares
Owns 50–75% of shares (as a firm)
Holds 50–75% of voting rights
British
Born October 1965 (61)
Former controllers (2)
20 July 2023
Ceased Houman Ashrafian — Owns 25–50% of shares
12 November 2021
Ceased Houman Ashrafian — Owns 25–50% of shares
Group structure 21 shown
Ownership group derived from the Companies House PSC register
SV Health Investors UK Limited This company
DDF 2 FP GP LLP Holds 25–50% of voting rights
DDF 2 FP LP Has significant influence or control
DDF 2 GP LLP Holds 25–50% of voting rights
SV Bco I FP GP LLP Holds 25–50% of voting rights
SV Bco I FP LP Right to appoint and remove a person
SV Bco I GP LLP Holds 25–50% of voting rights
Serenza Therapeutics Ltd Owns 25–50% of shares
SV Health Managers LLP Holds 75–100% of voting rights
Dementia Discovery GP LP Has significant influence or control
Harness Therapeutics Limited Holds 75–100% of voting rights
Loqus23 Therapeutics Limited Owns 25–50% of shares
SV DDF Number 1 Limited Owns 75–100% of shares
Dementia Discovery General Partner LLP Holds 75–100% of voting rights
SV DDF Number 2 Limited Owns 75–100% of shares
SV7 (Imf) FP LP Has significant influence or control
SV7 (Imf) FP GP LLP Holds 25–50% of voting rights
SV7 (Imf) GP LLP Holds 25–50% of voting rights
Cellinta Ltd Owns 75–100% of shares
SV8 Bio FP GP LLP Holds 25–50% of voting rights
SV8 Biotech FP LP Part right to 75–100% of surplus assets
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 October 2026 | Group of companies' accounts | 31 December 2025 | ||
| 15 October 2026 | Replacement filing of Confirmation Statement | 8 August 2016 | ||
| 9 June 2026 | Director's details changed | |||
| 19 January 2026 | Confirmation statement with no updates | 17 January 2026 | ||
| 29 September 2025 | Group of companies' accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →